Defective alterations in the collagen network to prostacyclin in COPD lung fibroblasts
Anna‐Karin Larsson‐Callerfelt(Lund University), Gunilla Westergren‐Thorsson(Lund University), Leif Bjermer(Lund University), Kristian Nihlberg(Lund University), Oskar Hällgren(Lund University), Annika Andersson‐Sjöland(Lund University), Lena Thiman(Lund University), Johan Björklund(Karolinska University Hospital), Claes‐Göran Löfdahl(Lund University), J. Kron(Lund University)
Cited by 36
Related Papers
MEDI-563, a humanized anti–IL-5 receptor α mAb with enhanced antibody-dependent cell-mediated cytotoxicity function
|Journal of Allergy and Clinical Immunology|2010|578
Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels
|CHEST Journal|2016|426
EUFOREA consensus on biologics for CRSwNP with or without asthma
|Allergy|2019|378
Benralizumab for the Prevention of COPD Exacerbations
|New England Journal of Medicine|2019|329
Tiotropium and olodaterol fixed-dose combination <i>versus</i> mono-components in COPD (GOLD 2–4)
|European Respiratory Journal|2015|322